Acquired haemophilia: an overview for clinical practice (Q38672497)

5 September 2017

title

Acquired haemophilia: an overview for clinical practice (English)

1 reference

5 September 2017

0 references

Craig M Kessler

1

1 reference

5 September 2017

Paul Knöbl

series ordinal

2

1 reference

5 September 2017

publication date

1 December 2015

1 reference

European Journal of Haematology

5 September 2017

published in

1 reference

5 September 2017

volume

95 Suppl 81

1 reference

5 September 2017

page(s)

36-44

1 reference

Consensus recommendations for the diagnosis and treatment of acquired hemophilia A

5 September 2017

cites work

1 reference

Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy

21 January 2018

1 reference

Acquired inhibitors of coagulation factors: part II.

21 January 2018

1 reference

Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.

21 January 2018

1 reference

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

21 January 2018

1 reference

The relevance of the bleeding severity in the treatment of acquired haemophilia - an update of a single-centre experience with 67 patients

21 January 2018

1 reference

Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO.

21 January 2018

1 reference

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

21 January 2018

1 reference

Guidelines for the management of hemophilia

21 January 2018

1 reference

Acquired factor VIII inhibitors: pathophysiology and treatment

21 January 2018

1 reference

Prevention and prediction of inhibitor risk

21 January 2018

1 reference

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

21 January 2018

1 reference

Hemophilia A in the third millennium

21 January 2018

1 reference

Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

21 January 2018

1 reference

Inhibitors of factor VIII in black patients with hemophilia

21 January 2018

1 reference

Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder.

21 January 2018

1 reference

Barriers to effective diagnosis and management of a bleeding patient with undiagnosed bleeding disorder across multiple specialties: results of a quantitative case-based survey

21 January 2018

1 reference

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

21 January 2018

1 reference

Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registry

21 January 2018

1 reference

A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project

21 January 2018

1 reference

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

21 January 2018

1 reference

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.

21 January 2018

1 reference

Factor VIII inhibitor epitopes and an enigma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EJH.12689

1 reference

5 September 2017

1 reference